Technical Analysis for VTRS - Viatris Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Historical VTRS trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Slingshot Bearish | Bearish Swing Setup | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Wide Bands | Range Expansion | 2.35% | |
Down 3 Days in a Row | Weakness | 2.35% | |
Down 4 Days in a Row | Weakness | 2.35% | |
Down 5 Days in a Row | Weakness | 2.35% | |
Oversold Stochastic | Weakness | 2.35% | |
Wide Bands | Range Expansion | 0.22% | |
Down 3 Days in a Row | Weakness | 0.22% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time | |
---|---|---|
1.5x Volume Pace | 1 day ago | |
Down 1% | 1 day ago | |
60 Minute Opening Range Breakdown | 1 day ago | |
Rose Above Previous Day's High | 2 days ago | |
Up 2% | 2 days ago |
Get a Trading Assistant
- Earnings date: ???
Viatris Inc. Description
Viatris Inc. is a new kind of healthcare company, empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway™. Formed in November 2020 through the combination of Mylan and Pfizer's Upjohn business, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, a growing portfolio of biosimilars and a variety of over-the-counter consumer products. With a global workforce of approximately 45,000, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India.
Classification
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Keywords: Biotechnology Life Sciences Infectious Diseases Pharmaceutical Companies Biosimilar
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 19.24 |
52 Week Low | 12.75 |
Average Volume | 11,381,496 |
200-Day Moving Average | 16.43 |
50-Day Moving Average | 17.24 |
20-Day Moving Average | 16.44 |
10-Day Moving Average | 14.63 |
Average True Range | 0.64 |
ADX | 36.99 |
+DI | 12.46 |
-DI | 39.04 |
Chandelier Exit (Long, 3 ATRs ) | 16.77 |
Chandelier Exit (Short, 3 ATRs ) | 15.22 |
Upper Bollinger Band | 20.19 |
Lower Bollinger Band | 12.70 |
Percent B (%b) | 0.16 |
BandWidth | 45.55 |
MACD Line | -1.03 |
MACD Signal Line | -0.70 |
MACD Histogram | -0.3359 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 14.86 | ||||
Resistance 3 (R3) | 14.78 | 14.38 | 14.70 | ||
Resistance 2 (R2) | 14.38 | 14.14 | 14.42 | 14.64 | |
Resistance 1 (R1) | 14.15 | 13.99 | 14.27 | 14.23 | 14.59 |
Pivot Point | 13.75 | 13.75 | 13.81 | 13.79 | 13.75 |
Support 1 (S1) | 13.52 | 13.51 | 13.64 | 13.60 | 13.23 |
Support 2 (S2) | 13.12 | 13.36 | 13.16 | 13.18 | |
Support 3 (S3) | 12.89 | 13.12 | 13.12 | ||
Support 4 (S4) | 12.97 |